Used primarily in peptide synthesis as a protected amino acid building block, this compound enables the incorporation of a fluorinated cyclohexyl alanine derivative into peptide chains. The Fmoc group allows for mild base-labile protection, compatible with solid-phase synthesis, making it valuable in the preparation of structurally modified peptides for pharmaceutical and biochemical research. The difluorocyclohexyl moiety enhances metabolic stability and influences conformational preference, which can improve peptide binding affinity, bioavailability, or resistance to enzymatic degradation. It is particularly useful in the development of peptidomimetics and in structure-activity relationship (SAR) studies.